Login / Signup

Have incidence rates of liver cancer peaked in the United States?

Jessica L PetrickAndrea A FlorioStephen CaldwellKatherine A McGlynn
Published in: Cancer (2020)
Declining HCC rates may persist due to improved treatment of the hepatitis C virus and/or competing causes of mortality among individuals with fatty liver disease.
Keyphrases
  • hepatitis c virus
  • risk factors
  • human immunodeficiency virus
  • cardiovascular events
  • cardiovascular disease
  • fatty acid
  • antiretroviral therapy